This report presents the forecast of the market for pain management through the year 2005. By 2005, it is anticipated that revenues will likely reach $32 billion, growing at an average annual rate of almost 12%.
Pain management pharmaceuticals currently hold the largest market revenue position, representing 97% and accounting for $16 billion of the total in 1999. Pharmaceuticals have long been the mainstay of pain management and it is anticipated that they will remain the largest market share throughout the forecast period.
Pain management devices account for 3%, representing $418.5 million in 1999. It is anticipated that the device segment will gain market revenue position due to technological advancements and a gradually declining cost increasing demand for current technologies
THE MARKET FOR PAIN MANAGEMENT
Pain is one of the most common ailments known to man and every person responds differently to pain. As pain is highly individualized and subjective, the person that is actually experiencing the pain is the only authority on that particular pain. Past pain experiences influence each individual's perception of pain, pain tolerance, and reaction to pain. Pain experiences can leave lasting emotional and physical impressions.
A number of factors influence an individual's reaction to pain including age, cultural background, degree of pain, perception, meaning of pain, past experiences, social expectations, physical and mental health, parental attitudes concerning pain, fear, anxiety, fatigue and the setting in which pain occurs.
Pain management, though constantly improving, remains suboptimal in some respects due to both inadequacies of health care delivery and in the range of available drugs and devices and other therapeutic modalities.
REASONS FOR THE STUDY AND ITS IMPORTANCE
This BCC study is presented to increase the awareness of pain management and identify pharmaceutical preparations and devices that are used to relieve various types of pain. The study analyzes the pain management market from different standpoints and addresses issues and trends affecting pain management. Pain management pharmaceutical and device manufacturers, driven by both research breakthroughs and increased recognition of expanding market opportunities, have stepped up the pace of development of new pain drugs and devices. Because of the evolving nature of this important area of medicine, executives of pain management pharmaceuticals and devices must remain ever vigilant of the changing environment and strive to keep abreast of new and currently used modalities in all facets of pain management.
OBJECTIVES OF THE STUDY AND ITS CONTRIBUTION
The objectives of the study are to present a comprehensive look at pain management, pharmaceutical, devices, and other treatment modalities. Markets are divided according to product category, as many of the products are used to relieve various types of pain and for different types of treatments. The report is directed to decision makers in the pain management industry as well as the providers of services in the pain management arena.
SCOPE AND CONTENT OF REPORT
This report is a comprehensive tool designed to provide an in-depth look at the market for pain management. The geographic scope of the report is the United States. The report describes the industry, its relationship to the healthcare industry and its participants, and trends for the future. Major markets are presented in two categories: pharmaceuticals and devices.
Within the pain management pharmaceuticals category, both prescription and over-the-counter products are addressed in all the primary product categories such as:
- Nonsteroid anti-inflammatories
- Migraine preparations
Within the pain management device category, primary product categories include:
- Transcutaneous electrical nerve stimulation (TENS)
- Spinal cord stimulators
- Neuromuscular stimulators
- Analgesia infusion devices
- Electrothermal and electromagneto therapies.
All categories are discussed in detail, describing each product, identifying current products on the market, measuring market size, identifying market drivers, forecasting for 2000-2005, and assessing the competitors and competitor market shares.
METHODOLOGY AND INFORMATION SOURCES
The information and analysis presented in this BCC report are based on an extensive survey of senior management in the pain management industry. Background information was obtained from various government, , medical trade and international journals. Key information from published literature was used to conduct interviews with over 100 industry executives and product managers to validate and obtain expert opinions on current and future trends in the pain management market. Interviews were also used to confirm and/or adjust market size and market share estimates, as well as in formulating market projections.
All market data pertains to the U.S. market at the manufacturer's level. Data are expressed in current U.S. dollars. The base year for data was 1999. Historical data are provided for 1998 and forecast data are provided for 2000, 2001 and 2005. Historical, base year and forecast data are provided for each market segment. Market shares are provided for each market segment for the 1999 base year.